| Year |
Citation |
Score |
| 2022 |
Zhang C, Yin G. Bayesian nonparametric analysis of restricted mean survival time. Biometrics. PMID 35034347 DOI: 10.1111/biom.13622 |
0.317 |
|
| 2020 |
Jin H, Yin G. Bayesian enhancement two-stage design with error control for phase II clinical trials. Statistics in Medicine. PMID 32854163 DOI: 10.1002/Sim.8734 |
0.341 |
|
| 2020 |
Zhang C, Wu Y, Yin G. Restricted mean survival time for interval-censored data. Statistics in Medicine. PMID 32767503 DOI: 10.1002/Sim.8699 |
0.414 |
|
| 2020 |
Yin G, Zhang C, Jin H. Statistical Issues and Lessons Learned from COVID-19 Clinical Trials with Lopinavir-Ritonavir and Remdesivir. Jmir Public Health and Surveillance. PMID 32589146 DOI: 10.2196/19538 |
0.311 |
|
| 2020 |
Yin G, Jin H. Comparison of transmissibility of coronavirus between symptomatic and asymptomatic patients: Reanalysis of the Ningbo COVID-19 data. Jmir Public Health and Surveillance. PMID 32442131 DOI: 10.2196/19464 |
0.305 |
|
| 2020 |
Shi H, Zhang T, Yin G. START: single-to-double arm transition design for phase II clinical trials. Pharmaceutical Statistics. PMID 32061188 DOI: 10.1002/Pst.2005 |
0.362 |
|
| 2020 |
Liu Y, Yin G. The Delaunay triangulation learner and its ensembles Computational Statistics & Data Analysis. 152: 107030. DOI: 10.1016/J.Csda.2020.107030 |
0.314 |
|
| 2020 |
Zhang A, Zhang H, Yin G. Adaptive iterative Hessian sketch via A-optimal subsampling Statistics and Computing. 30: 1075-1090. DOI: 10.1007/S11222-020-09936-8 |
0.319 |
|
| 2019 |
McCaw ZR, Yin G, Wei LJ. Using the Restricted Mean Survival Time Difference as an Alternative to the Hazard Ratio for Analyzing Clinical Cardiovascular Studies. Circulation. 140: 1366-1368. PMID 31634007 DOI: 10.1161/Circulationaha.119.040680 |
0.319 |
|
| 2019 |
Yang Z, Yin G. An alternative approach for estimating the number needed to treat for survival endpoints. Plos One. 14: e0223301. PMID 31626655 DOI: 10.1371/Journal.Pone.0223301 |
0.401 |
|
| 2019 |
Yin G, McCaw ZR. Design of Noninferiority Trials for Hypofractionated vs Conventional Radiotherapy Among Patients With Cancer. Jama Oncology. PMID 31369040 DOI: 10.1001/Jamaoncol.2019.2391 |
0.303 |
|
| 2019 |
Jiang F, Yin G, Dominici F. Bayesian Model Selection Approach to Multiple Change-Points Detection with Non-Local Prior Distributions Acm Transactions On Knowledge Discovery From Data. 13: 1-17. DOI: 10.1145/3340804 |
0.301 |
|
| 2019 |
Lam CK, Lin R, Yin G. Non‐parametric overdose control for dose finding in drug combination trials Journal of the Royal Statistical Society: Series C (Applied Statistics). 68: 1111-1130. DOI: 10.1111/Rssc.12349 |
0.348 |
|
| 2019 |
Jiang F, Cheng Q, Yin G, Shen H. Functional Censored Quantile Regression Journal of the American Statistical Association. 115: 931-944. DOI: 10.1080/01621459.2019.1602047 |
0.312 |
|
| 2018 |
Yin G, Chen N, Lee JJ. Bayesian Adaptive Randomization and Trial Monitoring with Predictive Probability for Time-to-event Endpoint. Statistics in Biosciences. 10: 420-438. PMID 30559900 DOI: 10.1007/S12561-017-9199-7 |
0.37 |
|
| 2018 |
Lin R, Yin G. Uniformly most powerful Bayesian interval design for phase I dose-finding trials. Pharmaceutical Statistics. PMID 30066466 DOI: 10.1002/Pst.1889 |
0.39 |
|
| 2018 |
Shi H, Yin G. Bayesian enhancement two-stage design for single-arm phase II clinical trials with binary and time-to-event endpoints. Biometrics. PMID 29466612 DOI: 10.1111/Biom.12864 |
0.359 |
|
| 2018 |
Jiang F, Ma Y, Yin G. Kernel-based adaptive randomization toward balance in continuous and discrete covariates Statistica Sinica. 28: 2841-2856. DOI: 10.5705/Ss.202016.0538 |
0.332 |
|
| 2018 |
Shi H, Yin G. Boosting conditional logit model Journal of Choice Modelling. 26: 48-63. DOI: 10.1016/J.Jocm.2017.07.002 |
0.386 |
|
| 2018 |
Li H, Cao Z, Yin G. Varying-association copula models for multivariate survival data Canadian Journal of Statistics. 46: 556-576. DOI: 10.1002/Cjs.11474 |
0.323 |
|
| 2017 |
Lin R, Yin G. STEIN: A simple toxicity and efficacy interval design for seamless phase I/II clinical trials. Statistics in Medicine. PMID 28786138 DOI: 10.1002/Sim.7428 |
0.368 |
|
| 2017 |
Shi H, Yin G. Landmark cure rate models with time-dependent covariates. Statistical Methods in Medical Research. 962280217708681. PMID 28627311 DOI: 10.1177/0962280217708681 |
0.387 |
|
| 2017 |
Zhang J, Yin G, Liu Y, Wu Y. Censored cumulative residual independent screening for ultrahigh-dimensional survival data. Lifetime Data Analysis. PMID 28550654 DOI: 10.1007/S10985-017-9395-2 |
0.326 |
|
| 2017 |
Yin G, Lam CK, Shi H. Bayesian Randomized Clinical Trials: From Fixed to Adaptive Design. Contemporary Clinical Trials. PMID 28455232 DOI: 10.1016/J.Cct.2017.04.010 |
0.391 |
|
| 2017 |
Zhao X, Wu Y, Yin G. Sieve maximum likelihood estimation for a general class of accelerated hazards models with bundled parameters Bernoulli. 23: 3385-3411. DOI: 10.3150/16-Bej850 |
0.349 |
|
| 2017 |
Shi H, Yin G. Bayesian Two-Stage Design for Phase II Clinical Trials with Switching Hypothesis Tests Bayesian Analysis. 12: 31-51. DOI: 10.1214/15-Ba988 |
0.302 |
|
| 2017 |
Duan X, Yin G. Ensemble Approaches to Estimating the Population Mean with Missing Response Scandinavian Journal of Statistics. 44: 899-917. DOI: 10.1111/Sjos.12281 |
0.377 |
|
| 2017 |
Dong F, Yin G. Maximum likelihood estimation for incomplete multinomial data via the weaver algorithm Statistics and Computing. 28: 1095-1117. DOI: 10.1007/S11222-017-9782-2 |
0.369 |
|
| 2016 |
Shi H, Yin G. Two-stage seamless transition design from open-label single-arm to randomized double-arm clinical trials. Statistical Methods in Medical Research. 962280215625681. PMID 28034171 DOI: 10.1177/0962280215625681 |
0.36 |
|
| 2016 |
Lin R, Yin G. Nonparametric overdose control with late-onset toxicity in phase I clinical trials. Biostatistics (Oxford, England). PMID 27549121 DOI: 10.1093/Biostatistics/Kxw038 |
0.373 |
|
| 2016 |
Wu Y, Yin G. Multiple imputation for cure rate quantile regression with censored data. Biometrics. PMID 27479513 DOI: 10.1111/Biom.12574 |
0.419 |
|
| 2016 |
Liu Y, Yin G. Partitioned log-rank tests for the overall homogeneity of hazard rate functions. Lifetime Data Analysis. PMID 26995734 DOI: 10.1007/S10985-016-9365-0 |
0.322 |
|
| 2016 |
Lin R, Yin G. Bootstrap aggregating continual reassessment method for dose finding in drug-combination trials The Annals of Applied Statistics. 10: 2349-2376. DOI: 10.1214/16-Aoas982 |
0.312 |
|
| 2016 |
Li H, Duan X, Yin G. Generalized Method of Moments for Additive Hazards Model with Clustered Dental Survival Data Scandinavian Journal of Statistics. 43: 1124-1139. DOI: 10.1111/Sjos.12232 |
0.436 |
|
| 2016 |
Xu J, Yin G, Ohlssen D, Bretz F. Bayesian two-stage dose finding for cytostatic agents via model adaptation Journal of the Royal Statistical Society. Series C: Applied Statistics. DOI: 10.1111/Rssc.12129 |
0.363 |
|
| 2016 |
Lin R, Liu Z, Zheng S, Yin G. Power computation for hypothesis testing with high-dimensional covariance matrices Computational Statistics and Data Analysis. 104: 10-23. DOI: 10.1016/J.Csda.2016.05.008 |
0.335 |
|
| 2016 |
Wu Y, Yin G. Cure rate quantile regression accommodating both finite and infinite survival times Canadian Journal of Statistics. 45: 29-43. DOI: 10.1002/Cjs.11306 |
0.432 |
|
| 2015 |
Lin R, Yin G. Bayes factor and posterior probability: Complementary statistical evidence to p-value. Contemporary Clinical Trials. 44: 33-35. PMID 26212520 DOI: 10.1016/J.Cct.2015.07.001 |
0.302 |
|
| 2015 |
Lin R, Yin G. Bayesian optimal interval design for dose finding in drug-combination trials. Statistical Methods in Medical Research. PMID 26178591 DOI: 10.1177/0962280215594494 |
0.311 |
|
| 2015 |
Morita S, Sakamaki K, Yin G. Detecting overall survival benefit derived from survival postprogression rather than progression-free survival. Journal of the National Cancer Institute. 107. PMID 25956357 DOI: 10.1093/Jnci/Djv133 |
0.328 |
|
| 2015 |
Jin IH, Huo L, Yin G, Yuan Y. Phase I trial design for drug combinations with Bayesian model averaging. Pharmaceutical Statistics. 14: 108-19. PMID 25641851 DOI: 10.1002/Pst.1668 |
0.433 |
|
| 2015 |
Ro K, Zou C, Wang Z, Yin G. Outlier detection for high-dimensional data Biometrika. 102: 589-599. DOI: 10.1093/Biomet/Asv021 |
0.373 |
|
| 2015 |
Wu Y, Yin G. Conditional quantile screening in ultrahigh-dimensional heterogeneous data Biometrika. 102: 65-76. DOI: 10.1093/Biomet/Asu068 |
0.325 |
|
| 2015 |
Wu Y, Ma Y, Yin G. Smoothed and Corrected Score Approach to Censored Quantile Regression With Measurement Errors Journal of the American Statistical Association. 110: 1670-1683. DOI: 10.1080/01621459.2014.989323 |
0.398 |
|
| 2014 |
Wang X, Zhang J, Yu L, Yin G. Generalized partially linear single-index model for zero-inflated count data. Statistics in Medicine. 34: 876-86. PMID 25421596 DOI: 10.1002/Sim.6382 |
0.421 |
|
| 2014 |
Cai J, Yin G, Lin B, Wang X, Liu X, Chen X, Yan D, Shan G, Qu J, Wu S. Roles of NFκB-miR-29s-MMP-2 circuitry in experimental choroidal neovascularization. Journal of Neuroinflammation. 11: 88. PMID 24886609 DOI: 10.1186/1742-2094-11-88 |
0.306 |
|
| 2014 |
Yin G, Zeng D, Li H. Censored quantile regression with varying coefficients Statistica Sinica. 24: 855-870. DOI: 10.5705/Ss.2011.195 |
0.421 |
|
| 2014 |
Zou C, Yin G, Feng L, Wang Z. Nonparametric maximum likelihood approach to multiple change-point problems The Annals of Statistics. 42: 970-1002. DOI: 10.1214/14-Aos1210 |
0.349 |
|
| 2013 |
Liu S, Yin G, Yuan Y. BAYESIAN DATA AUGMENTATION DOSE FINDING WITH CONTINUAL REASSESSMENT METHOD AND DELAYED TOXICITY. The Annals of Applied Statistics. 7: 1837-2457. PMID 24707327 DOI: 10.1214/13-Aoas661 |
0.405 |
|
| 2013 |
Ma Y, Yin G. Testing Overall and Subpopulation Treatment Effects with Measurement Errors. Statistica Sinica. 23: 1019-1042. PMID 24501537 DOI: 10.5705/Ss.2012.049 |
0.304 |
|
| 2013 |
Gu X, Yin G, Lee JJ. Bayesian two-step Lasso strategy for biomarker selection in personalized medicine development for time-to-event endpoints. Contemporary Clinical Trials. 36: 642-50. PMID 24075829 DOI: 10.1016/J.Cct.2013.09.009 |
0.33 |
|
| 2013 |
Guo Y, Xie D, Yan J, Cai J, Yin G, Wu L. Primary pulmonary rhabdomyosarcoma with brain metastases in a child: a case report with medico-legal implications. Journal of Forensic and Legal Medicine. 20: 720-3. PMID 23910869 DOI: 10.1016/j.jflm.2013.04.011 |
0.314 |
|
| 2013 |
Yin G, Zheng S, Xu J. Fractional dose-finding methods with late-onset toxicity in phase I clinical trials. Journal of Biopharmaceutical Statistics. 23: 856-70. PMID 23786314 DOI: 10.1080/10543406.2013.789892 |
0.369 |
|
| 2013 |
Yin G, Ma Y. Pearson-type goodness-of-fit test with bootstrap maximum likelihood estimation. Electronic Journal of Statistics. 7: 412-427. PMID 23720703 DOI: 10.1214/13-Ejs773 |
0.39 |
|
| 2013 |
Shi Y, Yin G. Escalation with overdose control for phase I drug-combination trials. Statistics in Medicine. 32: 4400-12. PMID 23630103 DOI: 10.1002/Sim.5832 |
0.366 |
|
| 2013 |
Yin G, Zheng S, Xu J. Two-stage dose finding for cytostatic agents in phase I oncology trials. Statistics in Medicine. 32: 644-60. PMID 22855354 DOI: 10.1002/Sim.5546 |
0.323 |
|
| 2013 |
Xu J, Yin G. Two-stage adaptive randomization for delayed response in clinical trials Journal of the Royal Statistical Society: Series C (Applied Statistics). 63: 559-578. DOI: 10.1111/Rssc.12048 |
0.371 |
|
| 2013 |
Wu Y, Yin G. Cure Rate Quantile Regression for Censored Data With a Survival Fraction Journal of the American Statistical Association. 108: 1517-1531. DOI: 10.1080/01621459.2013.837368 |
0.427 |
|
| 2012 |
Yin G, Chen N, Lee JJ. Phase II trial design with Bayesian adaptive randomization and predictive probability. Journal of the Royal Statistical Society. Series C, Applied Statistics. 61. PMID 24259753 DOI: 10.1111/J.1467-9876.2011.01006.X |
0.377 |
|
| 2012 |
Huo L, Yuan Y, Yin G. Bayesian Dose Finding for Combined Drugs with Discrete and Continuous Doses. Bayesian Analysis (Online). 7: 1035-1052. PMID 23956811 DOI: 10.1214/12-Ba735 |
0.349 |
|
| 2012 |
Lee JJ, Chen N, Yin G. Worth adapting? Revisiting the usefulness of outcome-adaptive randomization. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 18: 4498-507. PMID 22753588 DOI: 10.1158/1078-0432.Ccr-11-2555 |
0.361 |
|
| 2012 |
Diao G, Yin G. A general transformation class of semiparametric cure rate frailty models Annals of the Institute of Statistical Mathematics. 64: 959-989. DOI: 10.1007/S10463-012-0354-0 |
0.418 |
|
| 2011 |
Yuan Y, Yin G. BAYESIAN PHASE I/II ADAPTIVELY RANDOMIZED ONCOLOGY TRIALS WITH COMBINED DRUGS. The Annals of Applied Statistics. 5: 924-942. PMID 22375162 DOI: 10.1214/10-Aoas433 |
0.384 |
|
| 2011 |
Yin G, Ma Y, Liang F, Yuan Y. Stochastic Generalized Method of Moments. Journal of Computational and Graphical Statistics : a Joint Publication of American Statistical Association, Institute of Mathematical Statistics, Interface Foundation of North America. 20: 714-727. PMID 22375093 DOI: 10.1198/Jcgs.2011.09210 |
0.371 |
|
| 2011 |
Yuan Y, Yin G. Robust EM Continual Reassessment Method in Oncology Dose Finding. Journal of the American Statistical Association. 106: 818-831. PMID 22375092 DOI: 10.1198/Jasa.2011.Ap09476 |
0.411 |
|
| 2011 |
Arun BK, Dhinghra K, Valero V, Kau SW, Broglio K, Booser D, Guerra L, Yin G, Walters R, Sahin A, Ibrahim N, Buzdar AU, Frye D, Sneige N, Strom E, et al. Phase III randomized trial of dose intensive neoadjuvant chemotherapy with or without G-CSF in locally advanced breast cancer: long-term results. The Oncologist. 16: 1527-34. PMID 22042783 DOI: 10.1634/Theoncologist.2011-0134 |
0.326 |
|
| 2011 |
Yuan Y, Yin G. Dose-response curve estimation: a semiparametric mixture approach. Biometrics. 67: 1543-54. PMID 21627631 DOI: 10.1111/J.1541-0420.2011.01620.X |
0.396 |
|
| 2011 |
Garcia TP, Ma Y, Yin G. Efficiency improvement in a class of survival models through model-free covariate incorporation. Lifetime Data Analysis. 17: 552-65. PMID 21455700 DOI: 10.1007/S10985-011-9195-Z |
0.417 |
|
| 2011 |
Yuan Y, Yin G. Bayesian hybrid dose-finding design in phase I oncology clinical trials. Statistics in Medicine. 30: 2098-108. PMID 21365672 DOI: 10.1002/Sim.4164 |
0.363 |
|
| 2011 |
Lei X, Yuan Y, Yin G. Bayesian phase II adaptive randomization by jointly modeling time-to-event efficacy and binary toxicity. Lifetime Data Analysis. 17: 156-74. PMID 20364321 DOI: 10.1007/S10985-010-9163-Z |
0.407 |
|
| 2011 |
Ma Y, Yin G. Censored quantile regression with covariate measurement errors Statistica Sinica. 21: 949. DOI: 10.5705/Ss.2011.041A |
0.396 |
|
| 2010 |
Yuan Y, Yin G. Bayesian quantile regression for longitudinal studies with nonignorable missing data. Biometrics. 66: 105-14. PMID 19459836 DOI: 10.1111/J.1541-0420.2009.01269.X |
0.379 |
|
| 2010 |
Ma Y, Yin G. Semiparametric median residual life model and inference Canadian Journal of Statistics. 38: 665-679. DOI: 10.1002/Cjs.10076 |
0.334 |
|
| 2009 |
Yin G, Yuan Y. A latent contingency table approach to dose finding for combinations of two agents. Biometrics. 65: 866-75. PMID 18759848 DOI: 10.1111/J.1541-0420.2008.01119.X |
0.385 |
|
| 2009 |
Nieto-Barajas LE, Yin G. Bayesian cure rate model accommodating multiplicative and additive covariates Statistics and Its Interface. 2: 513-521. DOI: 10.4310/Sii.2009.V2.N4.A12 |
0.397 |
|
| 2009 |
Yin G. Bayesian generalized method of moments Bayesian Analysis. 4: 191-208. DOI: 10.1214/09-Ba407 |
0.362 |
|
| 2009 |
Yin G, Yuan Y. Bayesian Model Averaging Continual Reassessment Method in Phase I Clinical Trials Journal of the American Statistical Association. 104: 954-968. DOI: 10.1198/Jasa.2009.Ap08425 |
0.437 |
|
| 2009 |
Yuan Y, Yin G. Bayesian dose finding by jointly modelling toxicity and efficacy as time-to-event outcomes Journal of the Royal Statistical Society: Series C (Applied Statistics). 58: 719-736. DOI: 10.1111/J.1467-9876.2009.00674.X |
0.391 |
|
| 2009 |
Yin G, Yuan Y. Bayesian dose finding in oncology for drug combinations by copula regression Journal of the Royal Statistical Society: Series C (Applied Statistics). 58: 211-224. DOI: 10.1111/J.1467-9876.2009.00649.X |
0.378 |
|
| 2009 |
Li H, Yin G. Generalized method of moments estimation for linear regression with clustered failure time data Biometrika. 96: 293-306. DOI: 10.1093/Biomet/Asp005 |
0.414 |
|
| 2009 |
Yin G, Hui L. Least squares estimation of varying-coefficient hazard regression with application to breast cancer dose-intensity data Canadian Journal of Statistics. 37: 659-674. DOI: 10.1002/Cjs.10036 |
0.421 |
|
| 2008 |
Yuan Y, Yin G. Sequential continual reassessment method for two-dimensional dose finding. Statistics in Medicine. 27: 5664-78. PMID 18618901 DOI: 10.1002/Sim.3372 |
0.347 |
|
| 2008 |
Yin G. Bayesian transformation cure frailty models with multivariate failure time data. Statistics in Medicine. 27: 5929-40. PMID 18618427 DOI: 10.1002/Sim.3371 |
0.379 |
|
| 2008 |
Rivera E, Mejia JA, Arun BK, Adinin RB, Walters RS, Brewster A, Broglio KR, Yin G, Esmaeli B, Hortobagyi GN, Valero V. Phase 3 study comparing the use of docetaxel on an every-3-week versus weekly schedule in the treatment of metastatic breast cancer. Cancer. 112: 1455-61. PMID 18300256 DOI: 10.1002/Cncr.23321 |
0.332 |
|
| 2008 |
Yin G, Zeng D, Li H. Power-Transformed Linear Quantile Regression With Censored Data Journal of the American Statistical Association. 103: 1214-1224. DOI: 10.1198/016214508000000490 |
0.397 |
|
| 2008 |
Yin G, Li H, Zeng D. Partially Linear Additive Hazards Regression With Varying Coefficients Journal of the American Statistical Association. 103: 1200-1213. DOI: 10.1198/016214508000000463 |
0.413 |
|
| 2008 |
Ma Y, Yin G. Cure Rate Model With Mismeasured Covariates Under Transformation Journal of the American Statistical Association. 103: 743-756. DOI: 10.1198/016214508000000319 |
0.409 |
|
| 2008 |
NIETO-BARAJAS LE, YIN G. Bayesian Semiparametric Cure Rate Model with an Unknown Threshold Scandinavian Journal of Statistics. 35: 540-556. DOI: 10.1111/J.1467-9469.2007.00589.X |
0.385 |
|
| 2007 |
Cong XJ, Yin G, Shen Y. Marginal analysis of correlated failure time data with informative cluster sizes. Biometrics. 63: 663-72. PMID 17825000 DOI: 10.1111/J.1541-0420.2006.00730.X |
0.373 |
|
| 2007 |
Gonzalez RJ, Buzdar AU, Fraser Symmans W, Yen TW, Broglio KR, Lucci A, Esteva FJ, Yin G, Kuerer HM. Novel clinical trial designs for treatment of ductal carcinoma in situ of the breast with trastuzumab (herceptin). The Breast Journal. 13: 72-5. PMID 17214797 DOI: 10.1111/J.1524-4741.2006.00366.X |
0.319 |
|
| 2007 |
Yin G. Model checking for additive hazards model with multivariate survival data Journal of Multivariate Analysis. 98: 1018-1032. DOI: 10.1016/J.Jmva.2006.02.005 |
0.408 |
|
| 2007 |
Li H, Yin G, Zhou Y. Local likelihood with time-varying additive hazards model Canadian Journal of Statistics. 35: 321-337. DOI: 10.1002/Cjs.5550350208 |
0.41 |
|
| 2006 |
Yin G, Li Y, Ji Y. Bayesian dose-finding in phase I/II clinical trials using toxicity and efficacy odds ratios. Biometrics. 62: 777-84. PMID 16984320 DOI: 10.1111/J.1541-0420.2006.00534.X |
0.422 |
|
| 2006 |
Yin G, Zeng D. Efficient Algorithm for Computing Maximum Likelihood Estimates in Linear Transformation Models Journal of Computational and Graphical Statistics. 15: 228-245. DOI: 10.1198/106186006X100542 |
0.387 |
|
| 2006 |
Zeng D, Yin G, Ibrahim JG. Semiparametric transformation models for survival data with a cure fraction Journal of the American Statistical Association. 101: 670-684. DOI: 10.1198/016214505000001122 |
0.438 |
|
| 2005 |
Hanrahan EO, Broglio KR, Buzdar AU, Theriault RL, Valero V, Cristofanilli M, Yin G, Kau SW, Hortobagyi GN, Rivera E. Combined-modality treatment for isolated recurrences of breast carcinoma: update on 30 years of experience at the University of Texas M.D. Anderson Cancer Center and assessment of prognostic factors. Cancer. 104: 1158-71. PMID 16047352 DOI: 10.1002/Cncr.21305 |
0.331 |
|
| 2005 |
Yin G, Shen Y. Self-designing trial combined with classical group sequential monitoring. Journal of Biopharmaceutical Statistics. 15: 667-75. PMID 16022171 DOI: 10.1081/Bip-200062850 |
0.391 |
|
| 2005 |
Yin G. Bayesian cure rate frailty models with application to a root canal therapy study. Biometrics. 61: 552-8. PMID 16011704 DOI: 10.1111/J.1541-0420.2005.040336.X |
0.383 |
|
| 2005 |
Yin G, Ibrahim JG. A general class of Bayesian survival models with zero and nonzero cure fractions. Biometrics. 61: 403-12. PMID 16011686 DOI: 10.1111/J.1541-0420.2005.00329.X |
0.376 |
|
| 2005 |
Yin G, Shen Y. Adaptive design and estimation in randomized clinical trials with correlated observations. Biometrics. 61: 362-9. PMID 16011682 DOI: 10.1111/J.1541-0420.2005.00333.X |
0.419 |
|
| 2005 |
Caplan DJ, Cai J, Yin G, White BA. Root canal filled versus non-root canal filled teeth: a retrospective comparison of survival times. Journal of Public Health Dentistry. 65: 90-6. PMID 15929546 DOI: 10.1111/J.1752-7325.2005.Tb02792.X |
0.485 |
|
| 2005 |
Yin G, Zeng D. Pair chart test for an early survival difference. Lifetime Data Analysis. 11: 117-29. PMID 15747593 DOI: 10.1007/S10985-004-5643-3 |
0.37 |
|
| 2005 |
Yin G, Ibrahim JG. A class of Bayesian shared gamma frailty models with multivariate failure time data. Biometrics. 61: 208-16. PMID 15737095 DOI: 10.1111/J.0006-341X.2005.030826.X |
0.352 |
|
| 2005 |
Yin G, Cai J. Quantile regression models with multivariate failure time data. Biometrics. 61: 151-61. PMID 15737088 DOI: 10.1111/J.0006-341X.2005.030815.X |
0.564 |
|
| 2005 |
Zeng D, Yin G, Ibrahim JG. Inference for a class of transformed hazards models Journal of the American Statistical Association. 100: 1000-1008. DOI: 10.1198/016214504000001637 |
0.408 |
|
| 2005 |
Zeng D, Lin DY, Yin G. Maximum Likelihood Estimation for the Proportional Odds Model With Random Effects Journal of the American Statistical Association. 100: 470-483. DOI: 10.1198/016214504000001420 |
0.426 |
|
| 2004 |
Yin G, Hu J. Two simulation methods for constructing confidence bands under the additive risk model. Journal of Biopharmaceutical Statistics. 14: 389-402. PMID 15206535 DOI: 10.1081/Bip-120037188 |
0.339 |
|
| 2004 |
Yin G. Additive hazards model with multivariate failure time data Biometrika. 91: 801-818. DOI: 10.1093/Biomet/91.4.801 |
0.424 |
|
| 2003 |
Yin G, Cai J, Kim J. Quantile Inference with Multivariate Failure Time Data Biometrical Journal. 45: 602-617. DOI: 10.1002/Bimj.200390036 |
0.547 |
|
| Show low-probability matches. |